Overview Financials News + Filings Key Docs Charts Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Employment agrmnt Appointed CFO Quarterly results CC transcript Asset disposition Inv. presentation Acq. announced Director departure
|
MEDICINOVA INC (MNOV)
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
08/07/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
04/26/2023 |
8-K
| Quarterly results |
06/21/2022 |
8-K
| Quarterly results |
06/15/2022 |
8-K
| Quarterly results |
08/02/2021 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
07/23/2021 |
8-K
| Quarterly results |
06/17/2021 |
8-K
| Quarterly results |
05/18/2021 |
8-K
| Quarterly results |
05/05/2021 |
8-K
| Quarterly results |
02/01/2021 |
8-K
| Unregistered Sales of Equity Securities, Other Events, Financial Statements and Exhibits Interactive Data |
01/12/2021 |
8-K
| Quarterly results |
10/21/2020 |
8-K
| Resignation/termination of a director |
06/19/2020 |
8-K
| Quarterly results |
06/17/2020 |
8-K
| Quarterly results |
04/23/2020 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
10/28/2019 |
8-K
| Regulation FD Disclosure |
10/25/2019 |
8-K
| Quarterly results |
08/23/2019 |
8-K
| Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Financial Statements and Exhibits
Docs:
|
"UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15 of The Securities Exchange Act of 1934 Date of Report : August 23, 2019 MEDICINOVA, INC. DELAWARE 001-33185 33-0927979 4275 EXECUTIVE SQUARE, SUITE 300, LA JOLLA, CA 92037 Registrant's telephone number, including area code: 373-1500 Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions : ☐ Written communications pursuant to Rule 425 under the Securities Act ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act ☐ Pre-commencement communications pursuant to Rule 14d-2 under the Exchange Act ) ☐ Pre-commencement co...",
"Opinion of Gunderson Dettmer Stough Villeneuve Franklin & Hachigian, LLP",
"At Market Issuance Sales Agreement, by and between MediciNova, Inc. and B. Riley FBR, Inc" |
|
07/26/2019 |
8-K
| Regulation FD Disclosure |
07/25/2019 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
06/11/2019 |
8-K
| Quarterly results |
04/26/2019 |
8-K
| Regulation FD Disclosure |
04/25/2019 |
8-K
| Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits |
03/12/2019 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
02/14/2019 |
8-K
| Regulation FD Disclosure |
10/26/2018 |
8-K
| Quarterly results |
07/24/2018 |
8-K
| Regulation FD Disclosure |
06/11/2018 |
8-K
| Submission of Matters to a Vote of Security Holders |
06/05/2018 |
8-K
| Quarterly results |
04/26/2018 |
8-K
| Regulation FD Disclosure |
02/21/2018 |
8-K
| Other Events, Financial Statements and Exhibits |
02/14/2018 |
8-K
| Regulation FD Disclosure |
02/08/2018 |
8-K
| Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits |
11/13/2017 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
|
|
|